Features

• Detection of 21 HPV genotypes in one single reaction
• CE-IVD marked and MNPA registered
• WHO HPV LabNet Proficiency Test validated (2011, 2013, 2015&2017)
• The ONLY HPV assay appointed by the Cervical Cancer Prevention Program in China (Over three million tests performed in 2019)
• High clinical sensitivity and clinical specificity: >95% (compared to FDA approved kit)
• Promising results compared to Roche’s Linear Array; with a better detection of HPV 52
• Include amplification control (IC) and hybridization control (Biotin) for monitoring of the entire experimental process

Specimens

• Cervical swab
• Liquid based cytology specimen (e.g. Thinprep, Surepath, Roche Female Swab Sample Kit, Hybribio Female Sample Collection Kit)
• Urine
• Exfoliated skin cells using sandpaper around genital area (Male)